Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Japanese approval for Amplatzer Septal Occluder for atrial septal occlusion

Aug. 18, 2005

Astellas reports discovery of novel reverse NCX inhibitor YM-270951

Aug. 18, 2005

European MRP completed for Remodulin

Aug. 17, 2005

P-selectin inhibitor from Wyeth effective in models of vascular inflammation and atherosclerosis

Aug. 17, 2005

Urocortin 2 shows promise in the treatment of congestive heart failure

Aug. 16, 2005

Novel therapeutics for cardiovascular diseases reported

Aug. 11, 2005

NCX-6550 elicits superior antithrombosis and antiatherogenesis effects

Aug. 11, 2005

Novel NHE-1 inhibitor demonstrates preclinical cardioprotection

Aug. 11, 2005

Clinical evidence supports the use of tecadenoson in the management of PSVT

Aug. 10, 2005

GSK report on a novel agonist of LXRalpha and -beta

Aug. 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...